Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a 6-12 month period without a clear cause, oftentimes presents a diagnostic challenge in clinical practice. This article seeks to provide a comprehensive approach to the assessment and management of this condition.
The etiology of UWL is vast, ranging from malignancies, gastrointestinal disorders, endocrine abnormalities, psychiatric conditions, to infectious diseases. Malignancies, especially gastrointestinal and lung cancers, have been identified as the most common cause. However, no cause is found in up to 25% of cases, even after extensive evaluation.
A thorough history and physical examination should be the initial step in the evaluation of UWL. This should be followed by basic laboratory tests and imaging studies based on the suspected underlying cause. If these initial investigations are inconclusive, more specialized tests and referrals may be necessary. It is also crucial to consider the patient's age, as the risk of malignancy increases with age.
The management of UWL primarily involves treating the underlying cause. In cases where no cause is identified, the focus should be on nutritional support and close monitoring of the patient. Behavioral interventions may also be beneficial. In addition, patients should be reassured that a significant proportion of UWL cases remain idiopathic and are not associated with serious illness.
In conclusion, UWL is a complex condition that requires a systematic and patient-centered approach. While it can be a sign of serious underlying disease, it is important to remember that a significant proportion of cases remain unexplained. The primary goal should be to provide supportive care and reassurance to the patient while continuing to monitor for potential causes.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation